Dr. Jonathan Dunn, M.D.
What this data tells you about Dr. Dunn
Dr. Jonathan Dunn is a cardiovascular disease in South Miami, FL, with 13 years in practice. Based on federal Medicare data, Dr. Dunn performed 3,081 Medicare services across 1,584 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dunn received a total of $7,268 from 37 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dunn is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 900 | $0 | $1 |
| Electrocardiogram (EKG), 12-lead | 435 | $11 | $32 |
| Office visit, established patient (30-39 min) | 316 | $93 | $270 |
| Office visit, established patient (20-29 min) | 258 | $69 | $195 |
| Echocardiogram, transthoracic | 185 | $147 | $424 |
| Telephone medical discussion with physician, 11-20 minutes | 169 | $69 | $170 |
| New patient office visit (45-59 min) | 106 | $118 | $360 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 90 | $351 | $500 |
| Regadenoson injection (Lexiscan) for heart stress test | 88 | $41 | $110 |
| Remote patient monitoring management, 20 min/month | 78 | $39 | $105 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 77 | $50 | $150 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 45 | $361 | $960 |
| Ultrasound of both sides of head and neck blood flow | 44 | $149 | $416 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 40 | $52 | $160 |
| Hospital follow-up visit, high complexity | 35 | $102 | $220 |
| Initial hospital admission, high complexity | 34 | $148 | $430 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 24 | $22 | $57 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 24 | $684 | $1,860 |
| Hospital follow-up visit, moderate complexity | 23 | $68 | $158 |
| Limited ultrasound scan of abdomen | 22 | $74 | $196 |
| Ultrasound of heart, follow-up | 18 | $72 | $224 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $6 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $2 | $10 |
| New patient office visit (30-44 min) | 14 | $86 | $240 |
| EKG interpretation and report | 13 | $6 | $9 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 11 | $147 | $405 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dunn is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dunn experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Does Dr. Dunn receive payments from pharmaceutical companies?
How do Dr. Dunn's costs compare to other cardiovascular diseases in South Miami?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology